Skip to content
MyStudyTimes.com
Provider Reviews

IVIM Health vs Telos Rx: Which Compounded GLP-1 Option Fits You?

Rate this post

The direct comparison IVIM Health vs Telos Rx centers on satisfaction signals, pricing structure, and proprietary program claims. Early verdict: IVIM stands out for unusually strong third-party ratings and a structured GLP-1 ID protocol, while Telos Rx emphasizes low starting prices with clinician approval required.

Explore IVIM Health membership and free month code

Key differences at a glance for IVIM Health vs Telos Rx

This comparison uses only captured provider facts. The most distinctive differences are: third-party ratings and program claims, published pricing and membership details, compounded medications and regulatory notes, and how each frames clinician review and availability.

1) Third-party ratings and program claims

IVIM Health: The source documents IVIM’s dual 4.9-star rating on Google and Trustpilot, described as an unusually strong satisfaction signal. IVIM also promotes a proprietary GLP-1 ID protocol that the company says can accelerate weight loss outcomes by up to 40% compared to standard GLP-1 protocols; the source notes this is IVIM’s protocol claim and not an independent clinical trial.

See IVIM Health ratings and GLP-1 ID details

Telos Rx: The captured Telos information does not include third-party rating data. Telos frames its offer around clinician-reviewed prescriptions and molecule selection between semaglutide and tirzepatide but does not present a proprietary outcome claim in the captured evidence.

2) Pricing and membership structure

IVIM Health: Documented pricing includes semaglutide (compounded) at $75/mo and tirzepatide (compounded) at $133/mo on the captured landing-page evidence, plus a quoted $74.99/mo program fee in some materials and FAQ language stating IVIM starts at $99 for the first month with $174/month ongoing; new patients can use code GIFT75 for a free month membership and a no-obligation consultation (a $75 value).

Telos Rx: Captured Telos language emphasizes semaglutide “as low as $99 per month” and tirzepatide “as low as $139 per month” if a licensed provider approves you. Telos states “Pay $0 if not approved” and repeatedly notes prices are “as low as” figures and that your price depends on your plan. Both providers warn that prescriptions require clinician approval.

Check Telos Rx pricing and clinician review terms

3) Compounded medications and regulatory notes

Both IVIM Health and Telos Rx offer compounded semaglutide and tirzepatide. The captured evidence for both providers explicitly states these are compounded medications and are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. Both say prescriptions are subject to clinician review.

4) Clinician review, availability, and cancellation

IVIM: The source notes RX required after clinical evaluation and that compounded medications are prescribed only after consultation with an IVIM provider. IVIM materials also indicate not available in all states and that medications are prepared by independent, licensed compounding pharmacies.

Telos: The captured Telos content states treatment is available only when a licensed clinician determines it is medically appropriate, that compounded medications are prescription-only, and that you can cancel anytime with no penalties according to the landing-page copy.

Comparison table: IVIM Health vs Telos Rx

Criteria IVIM Health Telos Rx
Third-party ratings 4.9 stars on Google and Trustpilot Not provided in captured evidence
Proprietary program claim GLP-1 ID claims up to 40% faster weight loss (company claim) No proprietary outcome claim captured
Starting price shown Semaglutide $75/mo and tirzepatide $133/mo on landing page; FAQ notes $99 first month and $174/mo ongoing Semaglutide as low as $99/mo; tirzepatide as low as $139/mo
Free consultation / trial No-obligation free consult ($75 value) and GIFT75 free month code Pay $0 if not approved; no free-month code captured
Compounded medication note Compounded; not FDA-approved; prescribed after consultation Compounded; not FDA-approved; prescribed after clinician review
Cancellation FAQ indicates can cancel; membership details on site Cancel anytime, no penalties (captured copy)

Start IVIM’s no-obligation consultation

Safety, evidence, and what is not supplied

Both providers’ captured materials repeatedly state that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. IVIM cites internal and retrospective observational studies in Obesity Pillars for outcomes but the source clarifies those are not randomized head-to-head trials. Telos’s captured content does not include independent rating data or published outcome claims in the landing-page capture.

Conclusion: IVIM Health vs Telos Rx and how to choose

In the IVIM Health vs Telos Rx comparison, choose IVIM Health if you prioritize unusually strong third-party ratings, a structured GLP-1 ID program claim and an entry path with a documented free consultation and a free month code. Choose Telos Rx if your main consideration is lower advertised “as low as” starting prices for semaglutide and tirzepatide pending clinician approval and straightforward cancel-anytime language.

Review Telos Rx clinician approval and pricing

Choose IVIM Health if you want unusually strong third-party ratings and a clinician-guided protocol with a documented free consult and a free month offer. Choose Telos Rx if you want the lowest advertised starting price subject to clinician approval and clear cancel-anytime language. All claims above come from captured provider materials and preserve stated qualifiers about compounded medications and clinician review.

Ready to Compare GLP-1, NAD+, TRT Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.